Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
ZBH Zimmer Biomet Holdings
129.450+2.040+1.60%
Close
02/03 16:00 ET
129.4500.0000.00%
Post Mkt Price 02/03 17:07 ET
High
132.280
Open
127.610
Turnover
370.34M
Low
126.020
Pre Close
127.410
Volume
2.85M
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Zimmer Biomet (NYSE:ZBH) Posts Quarterly Earnings Results, Beats Expectations By $0.05 EPS
Zimmer Biomet (NYSE:ZBH – Get Rating) announced its earnings results on Friday. The medical equipment provider reported $1.88 EPS for the quarter, beating the consensus estimate of $1.83 by $0.05, Br
Zimmer Biomet (NYSE:ZBH) Updates FY 2023 Earnings Guidance
Zimmer Biomet (NYSE:ZBH – Get Rating) issued an update on its FY 2023 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of $6.95-$7.15 for the period, compar
Ambulatory Surgery Centers, Robotics Seen as Trends for Orthopedic Devices in 2023
Zimmer Biomet Holdings Inc. Stock Rises Friday, Outperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Zimmer Biomet Holdings Inc. (ZBH) rallied 1.60% to $129.45 Friday, on what proved to be an
Zimmer Biomet Holdings (ZBH) Receives a Hold From Needham
BTIG Sticks to Their Hold Rating for Zimmer Biomet Holdings (ZBH)
Investors Met With Slowing Returns on Capital At Zimmer Biomet Holdings (NYSE:ZBH)
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly, we'll want to see a proven return on capital employed (ROCE) that is increasing, a
Earnings Scheduled For February 3, 2023
Companies Reporting Before The Bell • Twin Disc (NASDAQ:TWIN) is estimated to report quarterly earnings at $0.06 per share on revenue of $67.70 million. • Piper Sandler (NYSE:PIPR) is projected to rep
Zimmer Biomet Holdings Q4 22 Earnings Conference Call At 8:30 AM ET
Zimmer Biomet Q4 Adjusted Earnings, Sales Increase
07:15 AM EST, 02/03/2023 (MT Newswires) -- Zimmer Biomet (ZBH) reported Q4 adjusted earnings Friday of $1.88 per diluted share, up from $1.79 a year earlier. Analysts polled by Capital IQ expected $1
Company Overview
More
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. The company operates through the following segments: Americas Orthopedics, EMEA, Asia Pacific, and Americas Spine and Global Dental. The Americas Orthopedics segment consists of the U.S. market and includes other North, Central, and South American markets for the firm’s orthopedic product categories. The EMEA segment focuses on Europe and includes the Middle East and African markets for all product categories except Dental. The Asia Pacific segment consists of Japan, China, and Australia and includes other Asian and Pacific markets for all product categories except Dental. The Americas Spine and Global Dental segment focuses on the U.S. market and includes other North, Central, and South American markets for the firm's spine business, and all geographic markets for its dental business. This segment is also involved in research, development engineering, medical education, and brand management. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
CEO： Mr. Bryan C. Hanson
Market： NYSE
Listing Date： 07/25/2001
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet